BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21520383)

  • 1. We can build it, but will they come?
    Gilchrist IC
    Catheter Cardiovasc Interv; 2011 May; 77(6):818-9. PubMed ID: 21520383
    [No Abstract]   [Full Text] [Related]  

  • 2. One-year clinical outcome in an unselected patient population treated with the Genous™ endothelial progenitor cell capturing stent.
    Klomp M; Beijk MA; Tijssen JG; de Winter RJ
    Catheter Cardiovasc Interv; 2011 May; 77(6):809-17. PubMed ID: 20853436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Anti-healing" versus "pro-healing".
    Seth DA
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):605-6. PubMed ID: 18360850
    [No Abstract]   [Full Text] [Related]  

  • 4. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
    Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying the National Institute for Clinical Excellence criteria to patients treated with the Genous™ Bio-engineered R stent™: a sub-study of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry.
    Klomp M; Damman P; Beijk MA; Silber S; Grisold M; Ribeiro EE; Suryapranata H; Wòjcik J; Sim KH; Tijssen JG; de Winter RJ;
    Heart Vessels; 2012 Jul; 27(4):360-9. PubMed ID: 21725668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting stents: safe but not sufficient.
    Vogel RA
    JACC Cardiovasc Interv; 2009 Jun; 2(6):513-4. PubMed ID: 19539254
    [No Abstract]   [Full Text] [Related]  

  • 7. Sirolimus- versus paclitaxel-eluting stents for unselected patients with coronary artery disease.
    Park SJ
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):13-4. PubMed ID: 21181967
    [No Abstract]   [Full Text] [Related]  

  • 8. If I've heard it once, I've heard it (not yet) a hundred times.
    Butman SM
    Catheter Cardiovasc Interv; 2011 Mar; 77(4):502. PubMed ID: 21351224
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug eluting stents in CTOs: why not?
    Vetrovec GW
    Catheter Cardiovasc Interv; 2011 Feb; 77(3):333-4. PubMed ID: 21328678
    [No Abstract]   [Full Text] [Related]  

  • 10. A critical appraisal of the Janus carbostent.
    Kornowski R
    Catheter Cardiovasc Interv; 2009 Feb; 73(2):249-50. PubMed ID: 19156897
    [No Abstract]   [Full Text] [Related]  

  • 11. Gone but not forgotten: the case for drug-eluting stents in percutaneous revascularization of the chronic coronary total occlusion.
    Tcheng JE; Zidar DA
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1266-8. PubMed ID: 20129554
    [No Abstract]   [Full Text] [Related]  

  • 12. Another small step for small vessels.
    Morrison DA
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):67-9. PubMed ID: 20578195
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimizing the impact of primary percutaneous coronary intervention in acute myocardial infarction.
    Satler LF
    Catheter Cardiovasc Interv; 2011 Feb; 77(2):201. PubMed ID: 21290554
    [No Abstract]   [Full Text] [Related]  

  • 14. Left main and high-risk PCI: what, exactly, is it high risk for?
    Safian RD
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):952-3. PubMed ID: 21598347
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term follow-up of the First In Man experience with everolimus-eluting stents.
    Kimmelstiel C
    Catheter Cardiovasc Interv; 2010 Jun; 75(7):1004-5. PubMed ID: 20517960
    [No Abstract]   [Full Text] [Related]  

  • 16. Better results with the new generation bare metal stents.
    Vik-Mo H
    Scand Cardiovasc J; 2009 Apr; 43(2):84-6. PubMed ID: 19117238
    [No Abstract]   [Full Text] [Related]  

  • 17. Do we really understand pimecrolimus?
    Vorpahl M; Finn AV; Nakano M; Virmani R
    JACC Cardiovasc Interv; 2009 Oct; 2(10):1025-7. PubMed ID: 19850265
    [No Abstract]   [Full Text] [Related]  

  • 18. The continuing diabetic drug-eluting stents saga from very-late stent thrombosis to very-late late loss.
    Mak KH
    JACC Cardiovasc Interv; 2011 Mar; 4(3):324-6. PubMed ID: 21435611
    [No Abstract]   [Full Text] [Related]  

  • 19. DES in SVGs: safe and at least short-term effective.
    Hillegass WB
    Catheter Cardiovasc Interv; 2011 Feb; 77(3):356-7. PubMed ID: 21328680
    [No Abstract]   [Full Text] [Related]  

  • 20. PCI in small vessels: the case for a drug-coated balloon based intervention.
    Zeymer U; Scheller B
    EuroIntervention; 2011 May; 7 Suppl K():K57-60. PubMed ID: 22027729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.